Please use this identifier to cite or link to this item:
|Title:||Troubleshooting left ventricular assist devices: modern technology and its limitations||Autores:||Toll Brunet, Alfredo Luis
Hernández Mejía, L.
|Researchers (UNIBE):||Toll Brunet, Alfredo Luis||Affiliations:||Facultad de Ciencias de la Salud||Research area:||Ciencias de la Salud||Keywords:||Left ventricular assist devices; Heart-assist devices; Advanced heart failure; Complications||Issue Date:||2021||Publisher:||Current Science, Inc.||Source:||Current Treatment Options in Cardiovascular Medicine, 23, 62||Journal:||Current Treatment Options in Cardiovascular Medicine||Volume:||23||Issue:||62||Abstract:||
Purpose of review:
As the incidence of heart failure continues to rise, modern generation left ventricular assist devices (LVADs) have become the primary therapeutic modality used as both bridge to transplant (BTT) and destination therapy (DT) in patients with acute and chronic heart failure. This review aims to highlight the progression of LVAD technology, outline LVAD complications and manifestations, and provide evidence-based therapeutic methods to troubleshoot such adverse events.
Despite modern innovation, LVAD adverse events continue to hinder the progress of HF paradigms and are associated with a rise in morbidity and mortality. Complications such as bleeding, pump thrombosis, right heart failure, infections, stroke, valvular insufficiency, and arrhythmias are among the most described.
While the management of LVAD complications is described, standardized guidelines are needed to properly identify and troubleshoot all the complications faced by this patient population to decrease morbidity and mortality further.
|Appears in Collections:||Publicaciones de la Facultad de Ciencias de la Salud|
Show full item record Recommend this item
Files in This Item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.